Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00933192
Other study ID # muscle ultrasound
Secondary ID
Status Completed
Phase N/A
First received July 2, 2009
Last updated April 15, 2010
Start date July 2009
Est. completion date March 2010

Study information

Verified date April 2010
Source Karl Landsteiner Institute of Remobilization and Functional Health
Contact n/a
Is FDA regulated No
Health authority Austria: Ethikkommission
Study type Observational

Clinical Trial Summary

The evaluation of skeletal muscle strength in severly ill or cognitive impaired patients is an unresolved problem especially during the rehabilitation process. The aim of this study is to correlate morphological parameters assessed with muscle ultrasound and isometric muscle strength to establish an objective progression parameter for rehabilitation therapies.


Recruitment information / eligibility

Status Completed
Enrollment 52
Est. completion date March 2010
Est. primary completion date March 2010
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria:

- group 1: patients between 18 and 35 years

- group 2: patients between 60 and 80 years

Exclusion Criteria:

- neuromuscular diseases

- hip or knee prosthesis in the investigated leg

- any trauma of the hip, knee or ankle of the investigated leg during the last 12 months

- cognitive impairments

- pregnancy

- diabetes mellitus Type II

- acute or chronic pain in the investigated leg

- chronic maligne or non - maligne diseases (of the heart, lung or kidney)

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


Intervention

Device:
Siemens Acuson Antares ultrasound
skeletal muscle ultrasound of the musculus quadriceps, on two different days, two observers

Locations

Country Name City State
Austria Karl Landsteiner Institute of Remobilisation and Functional Health Vienna

Sponsors (1)

Lead Sponsor Collaborator
Karl Landsteiner Institute of Remobilization and Functional Health

Country where clinical trial is conducted

Austria,